Digital Biomarkers Market Outlook:
Digital Biomarkers Market size was valued at approximately USD 5.15 billion in 2025 and is projected to reach around USD 36 billion by the end of 2035, rising at a CAGR of approximately 22% during the forecast period (2026-2035). In 2026, the industry size of digital biomarkers is estimated at USD 6.2 billion.
According to the data published by the World Health Organization in 2024 stated that more than 3 billion people globally were living with a neurological condition. This is further creating a substantial consumer base for remote monitoring and early intervention solutions. Additionally, the data published by the Alzheimer’s Association more than 7 million Americans have Alzheimer's. This highlights the urgent need for AI-enabled tools for cognitive assessment. Moreover, the higher risk of developing these ailments among older citizens is stimulating market growth.
The rising research and development in digital biomarkers is changing healthcare by bringing innovation to wearable devices. Such biomarkers are rendering insights into the progression of the disease and treatment response. Digital biomarkers are capable of tracking various factors to aid in support for the early detection. Various algorithms analyze the photoplethysmography signal to anticipate the occurrence of any adverse events. Moreover, various ongoing collaborations among the leading firms are fostering innovations in healthcare to give more precise patient-centric care.
